Tsann Ming Chu
#165,821
Most Influential Person Now
Tsann Ming Chu's AcademicInfluence.com Rankings
Tsann Ming Chulaw Degrees
Law
#2818
World Rank
#3505
Historical Rank
Common Law
#154
World Rank
#167
Historical Rank
Tsann Ming Chuphilosophy Degrees
Philosophy
#9755
World Rank
#13359
Historical Rank
Logic
#6714
World Rank
#8259
Historical Rank
Download Badge
Law Philosophy
Why Is Tsann Ming Chu Influential?
(Suggest an Edit or Addition)Tsann Ming Chu's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- LNCaP model of human prostatic carcinoma. (1983) (1887)
- Purification of a human prostate specific antigen. (1979) (1040)
- The LNCaP cell line--a new model for studies on human prostatic carcinoma. (1980) (592)
- Prostatic‐specific antigen: An immunohistologic marker for prostatic neoplasms (1981) (378)
- Prostate antigen: A new potential marker for prostatic cancer (1981) (363)
- A prostate antigen in sera of prostatic cancer patients. (1980) (350)
- Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassay. (1980) (308)
- Carcinoembryonic antigen in patients with different cancers. (1972) (283)
- Prostate antigen: a marker for human prostate epithelial cells. (1981) (214)
- Characterization of a new primary human pancreatic tumor line. (1986) (214)
- Prognostic importance of prostate-specific antigen for monitoring patients with stages B2 to D1 prostate cancer. (1985) (198)
- Use of human prostate-specific antigen in monitoring prostate cancer. (1981) (197)
- Carcinoembryonic Antigen (CEA) as a Prognostic and Monitoring Test in Clinically Complete Resection of Colorectal Carcinoma (1976) (154)
- Prostatic origin of tumors. An immunohistochemical study. (1980) (131)
- Evaluation of carcinoembryonic antigen in human mammary carcinoma. (1973) (126)
- Carcinoembryonic antigen (CEA) in patients with carcinoma of the digestive tract. (1972) (121)
- Relative reliability of five serially measured markers for prognosis of progression in prostate cancer. (1986) (118)
- CEA as a monitor of gastrointestinal malignancy (1975) (110)
- Multiple marker evaluation in human prostate cancer with the use of tissue-specific antigens. (1982) (110)
- Monoclonal antibodies (F36/22 and M7/105) to human breast carcinoma. (1983) (108)
- Characterization of the tumorigenic and metastatic properties of a human pancreatic tumor cell line (AsPC-1) implanted orthotopically into nude mice. (1985) (107)
- Human pancreatic adenocarcinoma: In vitro and in vivo morphology of a new tumor line established from ascites (2007) (100)
- The proteolytic activity of human prostate-specific antigen. (1984) (96)
- Hormones in renal cancer. (1977) (92)
- Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation. (1978) (87)
- A solid-phase fluorescent immunoassay for human prostatic acid phosphatase. (1978) (85)
- Carcinoembryonic antigen in patients with tumors of the urogenital tract (1972) (83)
- Demonstration of Carcinoembryonic Antigen in Normal Human Plasma (1972) (80)
- Relationship between antigen density and immunotherapeutic response elicited by monoclonal antibodies against solid tumors. (1984) (77)
- Comparison of estramustine phosphate, methotrexate and cis-platinum in patients with advanced, hormone refractory prostate cancer. (1983) (77)
- Tissue distribution of an epithelial and tumor-associated antigen recognized by monoclonal antibody F36/22. (1983) (73)
- CEA monitoring of palliative treatment for colorectal carcinoma. (1977) (72)
- A simplified purification procedure for human prostate antigen. (1982) (70)
- Serum prostatic antigen measurement in localized prostatic cancer: correlation with clinical course. (1982) (67)
- A comparison of estramustine phosphate and streptozotocin in patients with advanced prostatic carcinoma who have had extensive irradiation. (1977) (67)
- Experimental tumoricidal effects of monoclonal antibody against solid breast tumors. (1983) (67)
- Monoclonal antibodies to a human prostate antigen. (1982) (64)
- Comparison of estramustine phosphate and vincristine alone or in combination for patients with advanced, hormone refractory, previously irradiated carcinoma of the prostate. (1981) (61)
- Measurements of prolactin and androgens in patients with prostatic diseases. (1980) (55)
- A comparison of estramustine phosphate versus cis-platinum alone versus estramustine phosphate plus cis-platinum in patients with advanced hormone refractory prostate cancer who had had extensive irradiation to the pelvis or lumbosacral area. (1983) (54)
- Comparison of procarbazine, imidazole-carboxamide and cyclophosphamide in relapsing patients with advanced carcinoma of the prostate. (1979) (52)
- What's new in tumor markers for prostate cancer? (1986) (51)
- Monoclonal antibody (F5) to human prostate antigen. (1983) (50)
- Human tissue polypeptide antigen in breast cancer. (1979) (50)
- Evaluation of biological markers in bladder cancer. (1975) (50)
- Evaluation of a new radioimmunoassay method for carcinoembryonic antigen in plasma, with use of zirconyl phosphate gel. (1972) (49)
- National randomized study of chemotherapeutic agents in advanced prostatic carcinoma: a progress report. (1977) (45)
- Clinical significance of serum alkaline phosphatase isoenzyme levels in advanced prostatic carcinoma. (1978) (45)
- Purification and characterization of a new human prostatic acid phosphatase isoenzyme. (1983) (44)
- Expression of ductal carcinoma antigen in breast cancer sera as defined using monoclonal antibody F36/22. (1984) (44)
- Expression of prostatic acid phosphatase in human prostate cancer. (1981) (43)
- Two new, direct, and specific methods of acid phosphatase determination. National field trial. (1979) (41)
- The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. (1979) (40)
- A comparison of hydroxyurea, methyl-chloroethyl-cyclohexy-nitrosourea and cyclophosphamide in patients with advanced carcinoma of the prostate. (1981) (40)
- Isolation of glycoprotein antigen from ascites fluid of pancreatic carcinoma. (1977) (39)
- Prostate-specific antigen and early detection of prostate cancer. (1997) (39)
- Effect of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. (1986) (38)
- A solid-phase immunoadsorbent assay for serum prostatic acid phosphatase. (1980) (35)
- Differential localization of human pancreas cancer-associated antigen and carcinoembryonic antigen in homologous pancreatic tumoral xenograft. (1981) (35)
- Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9. (2013) (33)
- Reactivity of monoclonal antibody F36/22 with human ovarian adenocarcinomas. (1984) (32)
- Demonstration of two molecular variants of carcinoembryonic antigen by concanavalin A sepharose affinity chromatography. (1975) (32)
- Plasma carcinoembryonic antigen in renal cell carcinoma patients. (1974) (31)
- Recovery of immunologically reactive antibodies and antigens from breast cancer immune complexes by preparative isoelectric focusing. (1981) (30)
- Carcinoembryonic antigen (CEA) in feces and plasma of normal subjects and patients with colorectal carcinoma (1974) (29)
- Pharmacoclinical study of oral estramustine phosphate (Estracyt) in advanced carcinoma of the prostate. (1974) (29)
- Evaluation of the microleukocyte adherence inhibition assay as an immunodiagnostic test for pancreatic cancer. (1978) (28)
- Isoenzymes of human prostate acid phosphatase. (1978) (28)
- Isoelectric focusing--a new approach to the study of immune complexes. (1980) (28)
- IMMUNOCHEMICAL CHARACTERIZATION OF PROSTATIC ACID PHOSPHATASE WITH MONOCLONAL ANTIBODIES * (1982) (28)
- Value of new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer. (1980) (27)
- Enzyme markers in human prostatic carcinoma. (1977) (27)
- Immune complexes in breast cancer patients as detected by Clq binding (1979) (27)
- A statistical evaluation of baseline and follow‐up carcinoembryonic antigen in patients with resectable colorectal carcinoma (1981) (26)
- Immunoaffinity isolation of ductal carcinoma antigen using monoclonal antibody F36/22. (1984) (26)
- Carcinoembryonic antigen as a monitor of successful surgical resection in 130 patients with carcinoma of the lung. (1978) (26)
- Prostate-specific antigenic domain of human prostate specific antigen identified with monoclonal antibodies. (1989) (26)
- Immunochemical studies on carcinoembryonic antigen-reactive glycoproteins from carcinomas of the colon and breast separated by concanavalin A affinity chromatography. (1976) (25)
- The reaction between carcinoembryonic antigen and concanavalin A. (1974) (24)
- Fundamental biochemical and immunological aspects of prostatic acid phosphatase (1980) (23)
- Prostatic acid phosphatase: Where are we? (1978) (22)
- Tumor-associated antigens. (1975) (22)
- Prostatic acid phosphatase - the developing experience. (1979) (22)
- Homodimer and heterodimer subunits of human prostate acid phosphatase. (1991) (22)
- Circulating antibody to prostate antigen in patients with prostate cancer. (1984) (21)
- Isolation of prostatic acid phosphatase-binding immunoglobulin G from human sera and its potential for use as a tumor-localizing reagent. (1980) (20)
- Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphatase. (1980) (20)
- Carcinoembryonic antigen in 228 patients with carcinoma of the lung (1975) (19)
- Prostatic acid phosphatase and prostate-specific antigen in prostate cancer. (1982) (19)
- CIRCULATING ANTIBODY TO PROSTATE ANTIGEN IN PATIENTS WITH PROSTATIC CANCER a (1983) (19)
- Cell‐mediated immune status of colon cancer patients. Evaluation by dermal antigen testing, measurement of lymphocyte stimulation and counts of peripheral blood rosette‐forming cells (1977) (18)
- Comparative evaluation of serum acid phosphatase, urinary cholesterol, and androgens in diagnosis of prostatic cancer. (1975) (18)
- Potential therapeutic effect of adriamycin-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor. (1987) (18)
- Use of pancreas-specific antigen in immunodiagnosis of pancreatic cancer. (1982) (17)
- Prostate-specific antigen: questions often asked. (1990) (16)
- Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography. (1979) (15)
- Prostate‐specific antigen, p30, γ‐seminoprotein, and EI (1994) (15)
- Measurements of prolactin and androgens in patients with prostatic disease. (1977) (14)
- PROSTATE‐SPECIFIC ACID PHOSPHATASE VERSUS ACID PHOSPHATASE IN MONITORING PATIENTS WITH PROSTATE CANCER * (1982) (14)
- Identification of a macromolecule containing an anticarcinoembryonic antigen-reactive substance and immunoglobulin M in human pancreatic cancer. (1978) (14)
- Tumor antigen and acid phosphatase isoenzyme in prostatic cancer. (1975) (14)
- Tumor-associated antigen(s) from granulosa cell carcinomas of the ovary. (1974) (13)
- Human prostate epithelial cell-specific antigen. (1981) (12)
- Simultaneous evaluation of a pancreas-specific antigen and a pancreatic cancer-associated antigen in pancreatic carcinoma. (1984) (12)
- Detection of a breast tissue-associated antigen by antiserum to Raji cell-bound circulating immune complexes of human breast cancer. (1981) (12)
- Purification and characterization of a human pancreas-specific antigen. (1981) (11)
- Characterization of a Wilms' tumor model. (1975) (11)
- Glycoprotein exhibiting immunological and enzymatic activities of human prostatic acid phosphatase. (1983) (11)
- Immunologic markers and the diagnosis of prostatic cancer. (1984) (11)
- Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer. (1988) (11)
- Prostate-Specific Antigen (1992) (9)
- Purification of a human prostate specific antigen. 1979 [classical article]. (2002) (9)
- Immunotherapy in a spontaneously developed murine mammary carcinoma with syngeneic monoclonal antibody (2004) (9)
- Placenta-like isoenzyme of alkaline phosphatase in prostatic cancer. (1982) (9)
- Isoelectric focusing analysis of soluble immune complexes bound to protein A-Sepharose. (1981) (9)
- Prostatic cancer. Immunochemical detection of prostatic acid phosphatase in serum and bone marrow. (1978) (9)
- Evaluation of a human pancreas-specific antigen by enzyme-linked immunosorbent assay. (1981) (8)
- Immunologically reactive tryptic fragments of human prostatic acid phosphatase. (1984) (8)
- Solid‐phase immunofluorescent and immunoadsorbent assays of serum prostatic acid phosphatase (1980) (8)
- Simple assay for serum prostatic acid phosphatase with specific monoclonal antibody. (1983) (7)
- Purification of a human prostate specific antigen. 1979. (2002) (7)
- Prostate cancer-associated markers. (1990) (7)
- Carcinoma of prostate. Long-term survival after bilateral adrenalectomy. (1974) (6)
- Carcinoembryonic antigen in osteosarcoma (1977) (6)
- Analysis of erythrocytic polyamines by automated reverse‐phase liquid chromatography (1987) (6)
- PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN1 (2002) (6)
- Current status of carcinoembryonic antigen assay. (1975) (6)
- Immune complexes and cancer. (1983) (6)
- Prostate-specific antigen, p30, gamma-seminoprotein, and E1. (1994) (5)
- Purification and characterization of acid phosphatase from Dunning R3327H prostatic adenocarcinoma. (1980) (5)
- Monoclonal Antibodies ( F 36 / 22 and M 7 / 105 ) to Human Breast Carcinoma 1 (2006) (5)
- Hybridoma antibody to breast cancer immune complexes. (1982) (5)
- A new fluorescent immunoassay for human prostatic acid phosphatase in prostate cancer (SPIF). (1979) (5)
- Effects of high-energy shock waves on murine renal cell carcinoma. (1991) (5)
- Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography. (1980) (5)
- CARCINOEMBRYONIC ANTIGEN IN DERMATOSES (1976) (4)
- Tumor antigens as related to pancreatic cancer (1980) (4)
- Purification and characterization of ribonucleases from human seminal plasma. (1983) (4)
- Carcinoembryonic antigen. Current clinical status. (1974) (4)
- Which prostate antigen is which? (1985) (4)
- A new cell line for studies on human thyroid medullary carcinoma. Abstr. (1981) (3)
- Modern concepts of acid and alkaline phosphatase measurement. (1980) (3)
- Prostate-Specific Antigen (PSA) in Prostate Cancer: Observed vs. Predicted Progression Rates AT 3, 6 and 12 Months After an Elevated Value (1987) (3)
- Simultaneous determination of plasma and urinary carcinoembryonic antigen levels (1975) (3)
- Identification of a breast tumor-associated orosomucoid by concanavalin A affinity chromatography. (1978) (3)
- A new model for studies on human prostatic carcinoma. Abstr. (1979) (3)
- LNCaP Model of Human Prostatic Carcinoma1 (2006) (3)
- Simultaneous measurement of acid phosphatase activity in bone marrow and peripheral blood serum. (1977) (3)
- Long term stability of prostate specific antigen in native and acidified serum (1988) (2)
- Plasma membrane associated protease activity in human pancreatic cancer. (1979) (2)
- The effects of aminoglutethimide on prostatic function. (1974) (2)
- The effects of long-term alternate-day steroids on parameters of adrenal function in renal transplant patients. (1976) (2)
- [Prostate antigen as a tumor marker of prostate cancer: (2). Changes of prostate antigen values during anti-cancer chemotherapy]. (1984) (2)
- An Immunoglobulin M (IgM) Antibody to Carcinoembryonic Antigen (CEA)‐like Antigen in Human Pancreatic Cancer (1978) (2)
- Monoclonal Antibodies to Human Prostate Cancer-Related Antigens (1985) (2)
- Adrenal imaging with 131I-19-iodocholesterol following long-term alternate-day steroids. (1976) (1)
- [Prostate antigen as a tumor marker of prostate cancer. (1) Changes of prostate antigen values during anti-androgen therapy]. (1984) (1)
- Prostate Specific Antigen (PSA): The Historical Perspective (2020) (1)
- Carcinoembryonic antigen assay in thyroid screening (2004) (1)
- Experimental Immunotherapy of Xenografted Bladder Cancer in Nude Mice Using A Monoclonal Antibody Recognizing Blood Group-A Antigen (1987) (1)
- Human monoclonal antibody recognizing liver-type aldolase B. (1986) (1)
- Monoclonal antibody to plasma membrane antigen of human prostatic cancer cell line (1986) (0)
- Evaluationof a New RadioimmunoassayMethod for CarcinoembryonicAntigenin Plasma , with Useof ZirconylPhosphateGel (2004) (0)
- A Solid-PhaseFluorescentImmunoassayfor HumanProstaticAcid Phosphatase' (1978) (0)
- Immunologically reactive tryptic fragments of human prostatic acid phosphatase (2005) (0)
- Prostate-Specific Antigen: Questions Often (1990) (0)
- Antitumor effects of methotrexate-monoclonal anti-prostatic acid phosphatase antibody conjugate on human prostate tumor (1986) (0)
- Reflection on the Discovery of Carcinoembryonic Antigen , Prostate-Specific Antigen , and Cancer Antigens CA 125 and CA 19-9 Moderator : (2012) (0)
- The use of estramustine and prednimustine versus prednimustine alone in advanced metastatic prostatic cancer patients who have received prior irradiation. (1978) (0)
- Differential localization of human pancreas cancer associated antigen (pcaa) and carcinoembryonic antigen (cea) in homologous pancreatic tumor xenograft. Abstr. (1981) (0)
- Effect of verapamil on antitumor activity of adriamycin-monoclonal antibody conjugate against intraperitoneal human ovarian cancer xenograft (1988) (0)
- Monitoring of Breast Cancer with the AID of Tissue Polypeptide Antigen (1984) (0)
- Experimental immunochemotherapy of human prostate tumor with 5-fluorodeoxyuridine monoclonal anti-prostate acid phosphatase antibody conjugate (1988) (0)
- Monoclonal antibody to human pancreatic adenocarcinoma tissue (1985) (0)
- Reissued Date of Patent : Re . 33 , 405 Oct . 23 , 1990 Patent Number : (2017) (0)
- Hormones in renal cancer. (1976) (0)
- Tissue Tumor Polypeptide Antigen and Gastrointestinal Cancer (1984) (0)
- Milestone in Urology PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN 1 (2002) (0)
- Purification and Characterization of Acid Phosphatase from Dunning R 3327 H Prostatic Adenocarcinomi (2006) (0)
- ASSESSMENT OF TUMOR ASSOCIATED MONOCLONAL ANTIBODY IN IMMUNOTHERAPY IN SYNGENEIC MODEL (1987) (0)
- Radio immuno detection and immuno chemo therapy of xeno grafted human prostatic tumor using mono clonal antibody (1983) (0)
- Production of human monoclonal antibodies reactive with prostate specific antigen (1987) (0)
- Evaluation ofa NewRadioimmunoassay Method forCarcinoembryonic Antigen in Plasma, withUseofZirconyl Phosphate Gel (1972) (0)
- Differential Antigen Pancreatic Localization of Human Pancreas Carcinoembryonic Antigen in Cancer-Associated Homologous and (2012) (0)
- Carcinoembryonic Antigen in the Prognosis and Therapy Monitoring of Carcinoma Patients (1981) (0)
- Specificities of monoclonal antibodies against breast cancer immune complexes. Abstr. (1983) (0)
- Monoclonal Antibodies to a Human Prostate Antigen 1 (2006) (0)
- Letter: Carcinoembryonic antigen in dermatoses. (1976) (0)
This paper list is powered by the following services:
